GLENDA BALL: Open Payments
NPI 1215126107 · BLACKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$403 in 21 payments from 9 companies in 2025. Trend: 2023 $1,292 · 2024 $703 · 2025 $403
Food & beverage: $403
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 6 | $103 |
| Novo Nordisk Inc | 4 | $95 |
| Lilly USA, LLC | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Acella Pharmaceuticals, LLC | 2 | $33 |
| ABBVIE INC. | 1 | $29 |
| Sequel Med Tech, LLC | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: FREESTYLE LIBRE 3, Ozempic, MOUNJARO, Kerendia, NP Thyroid 60, QULIPTA, TWIIST, Rybelsus.
Industry payments across VA — which companies pay providers there.
